- China Overseas Land reported a 14.4% increase in contract sales for January 2025.
- Contracted sales for the month amounted to 12.02 billion yuan.
- Out of analysts’ recommendations, there are 29 “buy” ratings.
- There are 4 “hold” ratings for China Overseas Land.
- There are no “sell” ratings, indicating strong confidence in the company.
“`
A look at China Overseas Land & Investment Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
China Overseas Land & Investment Limited, a global provider of real estate services focusing on commercial properties, has received a positive outlook based on the Smartkarma Smart Scores analysis. With a strong emphasis on value and dividends, scoring 4 out of 5 on both factors, the company demonstrates promising investment potential in terms of financial return and stability. In terms of growth and momentum, China Overseas Land & Investment received scores of 3, indicating moderate performance in these areas. However, the company scored lower on resilience, with a score of 2, suggesting some vulnerability to market fluctuations.
In summary, China Overseas Land & Investment Limited stands out as a solid contender in the real estate sector, with a focus on developing, managing, and investing in commercial properties. The company’s high scores in value and dividends showcase its potential for long-term profitability and shareholder returns. While there are areas for improvement in terms of resilience, the overall outlook for China Overseas Land & Investment appears positive based on the Smartkarma Smart Scores assessment.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
